Jamie Orengo

15PUBLICATIONS
90CO-AUTHORS
AllergyAutoimmunityInnate immunityImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 15, 2026
Type-2-Inflammatory-Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 Blockade.

|Dec 23, 2025
IL-33 expands plasma cells, disrupts germinal centers, and increases autoantibody production in mice.

Eva Conde, Seblewongel Asrat, Andrea Vecchione

|Oct 29, 2025
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma.

Seblewongel Asrat, Wei Keat Lim, Subhashini Srivatsan

|Dec 14, 2024
Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II Study.

Sayantani B Sindher, Kari C Nadeau, R Sharon Chinthrajah

|Dec 14, 2024
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy.

R Sharon Chinthrajah, Sayantani B Sindher, Kari C Nadeau

|Nov 06, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection.

Christopher D Petro, Andrea T Hooper, Avery Peace

Pageof 3

Frequent Collaborators

6 joint publications

Andrew J Murphy

6 joint publications

Matthew Sleeman

6 joint publications

Jennifer D Hamilton

5 joint publications

Seblewongel Asrat